Notice on the Supplementary Situation of Publicized Drugs in Hebei Province

According to the centralized procurement of drugs throughout the province, from April 28, 2019 to May 8, the approved pharmaceutical and manufacturing enterprises were publicized and questioned and clarified. Please login to Hebei Pharmaceutical Centralized Purchasing Network, enter the drug approval platform with user name and password, and check it in the "Internal Notification Bulletin" column.
Question and clarification materials should be related documents, approval, explanation, screenshot of official website, etc. If the material is unrecognizable or forged, all the consequences will be borne by the enterprise itself. Drugs whose quotation is lower or equal to the lowest networking/winning bid price of other provinces (cities) are publicized by networking; drugs whose quotation is higher than the lowest networking/winning bid price of other provinces (cities) are disqualified from networking; drugs whose price has not been inquired into are suspended for the time being. Enterprises are allowed to make complaints and then verify them according to their complaints.
2026-10-20
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India Proposes New GMP Rules for Clinical Trial and API Manufacturing
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
6th Drug Safety Symposium 2026 to Focus on “Beyond Algorithms & Assumptions, What Actually Matters in Pharmacovigilance”
-
Roche Acquires Carmot for $3.1 Billion to Enter Obesity Drug Market
-
Two departments issued a document to guidethe strengthening of drug cases investigation and handling
-
National Health Care Commission: 50% of thecountry's public hospitals above the second level have carried out appointmentdiagnosis and treatment services
-
India starts testing a pharmaceuticalcompany's exports of cough syrup
-
Inmanar Announces Several BreakthroughSequencing Innovations
-
China's medical supplies supply securitycapabilities continue to enhance
-
244 medical device concept stocks roseindustry insiders said the process of domestic replacement is expected toaccelerate
Recommend Reading
-
New Ocean Freight GRI Takes Effect on Asia, Middle East and Africa Routes to U.S. and Canada
-
What Can $3.4 Billion Buy? Shin-Etsu Chemical’s Answer: Upstream Control of PVC
-
From Kitchen Herb to Feed Additive: EFSA Gives Green Light to Marjoram Oil—With a Caution for Handlers
-
Arkema Divests PVC Additives Business to Focus Resources on High-Performance Materials Market
-
Red Algae, Golden Promise—With a Daily Dose Warning: EFSA Clears Astaxanthin-Rich Algal Meal for New Foods
-
Business Society September 16, 2026 Hydrofluoric Acid Trend Analysis: Fluctuating Trend
-
Geopolitical Risks Significantly Cooled, Oil Prices Fell by More Than 3%
-
Business Society’s Acrylic Acid Trend Analysis for September 16, 2026: Strong Consolidation
-
On March 11, the Chinese acrylonitrile market remained stable and organized
-
Business Society, September 29, 2026: Fuel Oil 180CST Trend Analysis – Volatility